Primary Record
cefetamet
- In stock
- 7,447 g
- Purity
- 98.4 %
- CAS
- 65052-63-3
Compound Identifiers & Properties
- CAS
- 65052-63-3
- PubChem CID
- 5487888
- SMILES
- CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3=CSC(=N3)N)SC1)C(=O)O
- Canonical SMILES
- CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(C)CS[C@H]12)c1csc(N)n1
Names & Synonyms
- cefetamet
- Cefetametum
- Deacetoxycefotaxime
- Cefetamet hydrochloride
- Altamet
- Cepime O
- Cefetamet acid
- Cefetametum [Latin]
- 65052-63-3
- Deacetylcefotaxime
- Desacetylcefotaxim
- Cefetamet [USAN:INN]
- Cefotaxime EP Impurity A
- Cefetamet (Standard)
- AC1NUPYF
- CEFETAMET [INN]
- CEFETAMET [MI]
- Cefetamet (USAN/INN)
- CEFETAMET [USAN]
- RefChem:574971
- C14H15N5O5S2
- Deacetoxycefotaxime, 97%
- CEFETAMET [MART.]
- UNII-4R5TV783X3
- CEFETAMET [USP-RS]
- CEFETAMET [WHO-DD]
- LY097964
- 4R5TV783X3
- Antibiotic Ro 15-8074
- SCHEMBL65620
- Ro-15-8074
- LY-97964
- Cefetamet pivoxil hydrochloride
- CHEBI:135629
- DTXSID00867110
- Cefetamet acid;Cefetamet;Deacetoxycefotaxime
- Ro 15-8074
- CEFETAMET [USP IMPURITY]
- CHEMBL2103764
- SCHEMBL27492188
- GTPL12416
- HY-A0111R
- DTXCID80820708
- J01DA26
- MFCD00864836
- CEFETAMETPIVOXILHYDROCHLORIDE
- HY-A0111
- MFCD00870989
- ZINC26892317
- AKOS015898798
- AN-8574
- C14-H15-N5-O5-S2
- CID5487888
- DB13504
- LY-097964
- CID:5487888
- AS-33463
- DA-51747
- FR 13300
- FR-13300
- H783
- J23.711F
- LY 97964
- SID:375590887
- CEFOTAXIME IMPURITY A [EP IMPURITY]
- LS-176423
- CS-0014040
- NS00001481
- (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- A-2176
- D03424
- 052C633
- A834955
- C047444
- CEFOTAXIME SODIUM IMPURITY A [EP IMPURITY]
- I09-1527
- Q1083757
- BRD-K27798832-001-01-5
- CEFOTAXIME SODIUM IMPURITY A (REFERENCE GRADE)
- (6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime)
- 2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido-3-desacetoxyceph-3-em-4-carboxylic acid
- (6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-methyl-8-oxo-, (6R,7R)-
- (6R)-3-Methyl-7alpha-[[(2-amino-4-thiazolyl)[(Z)-methoxyimino]acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]octa-2-ene-2-carboxylic acid
- (6R,6beta)-7alpha-[[(2-Amino-4-thiazolyl)[(Z)-methoxyimino]acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]octa-2-ene-2-carboxylic acid
- (6R,7R)-7-((2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
- (6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrochloride
- (6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7-[[(Z)-(2-Aminothiazole-4-yl)(methoxyimino)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]octa-2-ene-2-carboxylic acid
- 3-methyl-7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3,4-didehydrocepham-4-carboxylic acid
- 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(Z)))-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-methyl-8-oxo-, (6R,7R)-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-methyl-8-oxo-, (6R,7R)-; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-methyl-8-oxo-, [6R-[6a,7ss(Z)]]-; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-methyl-8-oxo-, (6R,7R)- (9CI); (6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Altamet; Antibiotic Ro 15-8074; Cefetamet; Cepime O; Deacetoxycefotaxime; FR 13300; LY 97964; Ro 15-8074; Ro 15-8074/005; Ultipime O
- 724438-16-8
- 7Beta-(2-(2-Aminothiazol-4-Yl)-2-Methoxyiminoacetamido)-3-Methyl-3-Cephem-4-Carboxylic Acid Glycylam
- 90712-47-3